Abstract
TC count and aneuploidy score of cfDNA can predict clinical response to radium-223 in patients with mCRPC.
Cite
CITATION STYLE
APA
de Jong, A. C., Isebia, K. T., Ling, S. W., de Weerd, V., Van, N. M., Kraan, J., … Wilting, S. M. (2023). Liquid Biopsies for Early Response Evaluation of Radium-223 in Metastatic Prostate Cancer. JCO Precision Oncology, (7). https://doi.org/10.1200/po.23.00156
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free